The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 2001;345(7):552.

Original Article
Volume 344:1567-1571 May 24, 2001 Number 21
NextNext

Maternal and Fetal Outcomes of Subsequent Pregnancies in Women with Peripartum Cardiomyopathy
Uri Elkayam, M.D., Padmini P. Tummala, M.D., Kalpana Rao, M.D., Mohammed W. Akhter, M.D., Ilyas S. Karaalp, M.D., Omar R. Wani, M.D., Afshan Hameed, M.D., Israel Gviazda, B.S., and Avraham Shotan, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Editorial
 by Reimold, S. C.

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-PubMed Citation
ABSTRACT

Background Peripartum cardiomyopathy is a rare but sometimes fatal form of heart failure. Little is known about the outcomes of subsequent pregnancies in women who have had the disorder.

Methods Through a survey of members of the American College of Cardiology, we identified 44 women who had had peripartum cardiomyopathy and had a total of 60 subsequent pregnancies. We then reviewed the medical records of these women and interviewed the women or their physicians.

Results Among the first subsequent pregnancies in the 44 women, 28 occurred in women in whom left ventricular function had returned to normal (group 1) and 16 occurred in women with persistent left ventricular dysfunction (group 2). The pregnancies were associated with a reduction in the mean (±SD) left ventricular ejection fraction both in the total cohort (from 49±12 percent to 42±13 percent, P<0.001) and in each group separately (from 56±7 percent to 49±10 percent in group 1, P=0.002; and from 36±9 percent to 32±11 percent in group 2, P=0.08). During these pregnancies, symptoms of heart failure occurred in 21 percent of the women in group 1 and 44 percent of those in group 2. The mortality rate was 0 percent in group 1 and 19 percent in group 2 (P=0.06). In addition, the frequency of premature delivery was higher in group 2 (37 percent vs. 11 percent), as was that of therapeutic abortions (25 percent vs. 4 percent).

Conclusions Subsequent pregnancy in women with a history of peripartum cardiomyopathy is associated with a significant decrease in left ventricular function and can result in clinical deterioration and even death.


Source Information

From the Section of Heart Failure, Division of Cardiology, Department of Medicine (U.E., P.P.T., K.R., M.W.A., I.S.K., O.R.W., I.G., A.S.), and the Department of Obstetrics and Gynecology (A.H.), University of Southern California School of Medicine, Los Angeles.

Address reprint requests to Dr. Elkayam at the Section of Heart Failure, Division of Cardiology, University of Southern California School of Medicine, LAC/USC Medical Center, 2025 Zonal Ave., Rm. 7621, Los Angeles, CA 90033, or at elkayam{at}hsc.usc.edu.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.